PE-backed Cosette Pharmaceuticals to acquire Mayne Pharma for $430m

Headquartered in Bridgewater, New Jersey, Cosette is a drug developer.

25 February 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals North America US Healthcare Briefs